Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Novartis U.S. Rx Marketing Head Schofield Joins From Pharmacia

Executive Summary

Novartis' efforts to reinvigorate its U.S. pharmaceuticals business in 2001 will be led by former Pharmacia VP-U.S. Sales Greg Schofield.

You may also be interested in...



Pharmacia North America Rx President Is Spiers; Hassan Adds Chairman Title

Pharmacia North American Pharmaceuticals President Mark Spiers will lead the company's search for a new head of U.S. sales.

Pharmacia North America Rx President Is Spiers; Hassan Adds Chairman Title

Pharmacia North American Pharmaceuticals President Mark Spiers will lead the company's search for a new head of U.S. sales.

SmithKline IBS Research Is One Of Nine Divestments Under FTC Order

SmithKline Beecham is required to divest its rights to Alizyme's irritable bowel syndrome therapy renzapride under the FTC consent order allowing the GlaxoSmithKline merger despite Glaxo's recent withdrawal of Lotronex.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS037109

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel